S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

KRON Kronos Bio Inc

1.01

-0.025 (-2.42%)

Jan 31 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Kronos Bio (NASDAQ:KRON)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Kronos Bio Charts.

Kronos Bio (NASDAQ:KRON)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Kronos Bio Charts.

Kronos Bio Inc News

California Biotech Stock Bid Up Prior To Opening Bell On Major Announcement
Wednesday 27 November 2024 (2 months ago) • AllPennyStocks.com

Kronos Bio Announces CEO Transition and Reduction in Force
Wednesday 27 November 2024 (2 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024
Thursday 14 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives
Wednesday 13 November 2024 (3 months ago) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma
Tuesday 5 November 2024 (3 months ago) • GlobeNewswire Inc.

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors
Wednesday 23 October 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 15 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 15 October 2024 (4 months ago) • Edgar (US Regulatory)

Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors
Wednesday 9 October 2024 (4 months ago) • GlobeNewswire Inc.

More Kronos Bio Inc News Articles

Northwest Biotherapeutics (QB)

Bioelectronics (PK)

Lightwave Logic

North Bay Resources (PK)

Fannie Mae (QB)

Elite Pharmaceuticals (QB)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions